Table 2

Patient demographics and disease characteristics
Age (years)
  Median (range) 49 (15–82)
Gender N %
  Men 74 69.2
  Women 33 30.8
Performance status
  0 38 35.5
  1-2 69 64.5
T classification
  T1 23 21.5
  T2 40 37.4
  T3 16 14.9
  T4 28 26.2
  T1+T2 63 58.9
  T3+T4 44 41.1
N classification
  N0 15 14.0
  N1 27 25.2
  N2 44 41.1
  N3a 4 3.7
  N3b 17 15.9
  N0+N1 42 39.3
  N2+N3 65 60.7
Clinical stage
  II-III 64 59.8
  IV 43 40.2
WHO classification
  Type I 10 9.3
  Type II 21 19.6
  Type III 76 71.0
History of smoking
  No 71 66.4
  Yes 36 33.6
Alcohol abuse
  No 100 93.5
  Yes 7 6.5
Hemoglobin level
  ≥12 10 9.3
  <12 94 87.9
  Unknown 3 2.8
Best Response Group A Group B
  CR 42 58 38 55
  PR 18 25 21 30
  ORR 60 83 59 85
  SD 3 4 2 3
  PD 2 3 5 7
  NE 7 10 3 4

CR: complete response; PR: partial response; ORR: overall response rate; SD: stable disease; PD: progressive disease; NE: not evaluated.

Krikelis et al.

Krikelis et al. BMC Clinical Pathology 2013 13:1   doi:10.1186/1472-6890-13-1

Open Data